Meng Shan-Shan, Gao Rong, Yan Bing-di, Ren Jin, Wu Fei, Chen Peng, Zhang Jie, Wang Li-Fang, Xiao Yuan-Ming, Liu Jing
Department of Respiratory Medicine, The Second Hospital of Jilin University, No.218, Ziqiang Street, Nanguan District, Changchun, China.
Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
Respir Res. 2016 Sep 20;17(1):114. doi: 10.1186/s12931-016-0430-8.
Maternal allergic disease history and impaired regulatory T-cells (Tregs) are critical risk factors for allergy development in children. However, the mechanisms that underlie these risk factors remain poorly defined. Therefore, the aim of this study was to assess whether maternal allergies affect the Tregs of offspring and lead to allergy development in childhood.
A total of 332 mothers of healthy newborns (234 from no allergic mothers, 98 from allergic mothers) were recruited to this study. Detailed questionnaires were administered yearly to determine the allergy status of the mothers and the newborns from birth to 3 years of age. Cord blood samples obtained at the time of birth were analysed for Treg counts, as well Treg activity, based on their response to Toll-like receptor (TLR) stimuli such as lipid A (LPA) and peptidoglycans (PPG). Surface markers, associated genes, suppressive capacity, and cytokine levels of Tregs were also measured. Possible correlations between Treg activity and maternal or neonate allergies were assessed. In addition, environmental microbial content and other known risk factors for allergies were measured.
Cord blood mononuclear cells (CBMCs) from offspring with allergic mothers showed fewer CD4(+)CD25(+)FOXP3(+) T cells, lower expression levels of associated genes, and reduced cytokine production of interleukin (IL)-10 and interferon-γ (P < 0.05), especially via the PPG-TLR2 pathway. Suppression of effector T cells by Tregs from children of mothers with allergies was impaired, especially IL-13 production by Type 2 T helper (Th2) cells (P = 0.026). Children who developed allergies in the first 3 years of life had lower numbers of CD4(+)CD25(+)FOXP3(+) T cells and reduced FOXP3 expression and IL-10 production as newborns (P < 0.05). Maternal allergic background was identified as a risk factor for allergy development in the children (Odds ratio (OR) = 2.46, 95 % CI = 1.05-5.79); while declining Treg numbers, IL-10 production, and FOXP3 expression in neonates (PPG and LPA stimulated) were identified as independent risk factors for allergic diseases in offspring at 3 years of age after adjusting for maternal allergic history and environmental factors (P < 0.05).
Maternal allergy correlated with impaired Tregs in neonates, and this could enhance the susceptibility of offspring to allergic diseases in early childhood due to an imbalance of Th1 and Th2 cells.
母亲的过敏性疾病史和调节性T细胞(Tregs)功能受损是儿童发生过敏的关键危险因素。然而,这些危险因素背后的机制仍不清楚。因此,本研究的目的是评估母亲的过敏是否会影响子代的Tregs,并导致儿童期过敏的发生。
本研究共招募了332名健康新生儿的母亲(234名来自无过敏母亲,98名来自过敏母亲)。每年进行详细问卷调查,以确定母亲和新生儿从出生到3岁的过敏状态。分析出生时采集的脐带血样本中的Treg计数以及基于其对Toll样受体(TLR)刺激(如脂多糖(LPA)和肽聚糖(PPG))的反应的Treg活性。还测量了Tregs的表面标志物、相关基因、抑制能力和细胞因子水平。评估了Treg活性与母亲或新生儿过敏之间的可能相关性。此外,还测量了环境微生物含量和其他已知的过敏危险因素。
过敏母亲子代的脐带血单个核细胞(CBMCs)显示CD4(+)CD25(+)FOXP3(+) T细胞数量减少、相关基因表达水平降低以及白细胞介素(IL)-10和干扰素-γ的细胞因子产生减少(P < 0.05),尤其是通过PPG-TLR2途径。过敏母亲子代的Tregs对效应T细胞的抑制作用受损,尤其是2型辅助性T细胞(Th2)产生IL-13的能力受损(P = 0.026)。在生命的前3年发生过敏的儿童,其出生时CD4(+)CD25(+)FOXP3(+) T细胞数量较少,FOXP3表达和IL-10产生减少(P < 0.05)。母亲的过敏背景被确定为儿童过敏发生的危险因素(优势比(OR)= 2.46,95%置信区间(CI)= 1.05 - 5.79);而在调整母亲过敏史和环境因素后,新生儿(PPG和LPA刺激)中Treg数量、IL-10产生和FOXP3表达下降被确定为3岁后代过敏性疾病的独立危险因素(P < 0.05)。
母亲过敏与新生儿Tregs功能受损相关,这可能由于Th1和Th2细胞失衡而增加子代在幼儿期患过敏性疾病的易感性。